Recombinant Human TNFR1 Protein，His

Tumor necrosis factor receptor 1 (TNFR1) is a critical receptor in the inflammatory and immune response, primarily mediating the effects of tumor necrosis factor-alpha (TNF-α), a pro-inflammatory cytokine. Research on TNFR1 is essential due to its role in various pathological conditions, including autoimmune diseases, cancer, and neurodegenerative disorders. TNFR1 signaling pathways are complex, leading to both cell survival and apoptosis, which are pivotal in maintaining immune homeostasis. Understanding these pathways can reveal potential therapeutic targets for modulating immune responses. The development of recombinant TNFR1 proteins has advanced our ability to study this receptor's function in vitro and in vivo. By producing TNFR1 as a recombinant protein, researchers can investigate its interactions with ligands and downstream signaling molecules, elucidate its structural properties, and assess its potential as a therapeutic agent. Moreover, recombinant TNFR1 proteins facilitate the development of antagonists or agonists that can selectively modulate TNF-α signaling, offering insights into new treatment strategies for diseases driven by TNF-α dysregulation. As a result, ongoing studies of TNFR1 not only enhance our understanding of its biological roles but also pave the way for innovative approaches in therapeutics targeting inflammation and immune-related disorders.